Community Health Workers and mHealth for Sickle Cell Disease Care
Sickle Cell Disease
About this trial
This is an interventional supportive care trial for Sickle Cell Disease focused on measuring Sickle Cell Disease
Eligibility Criteria
Inclusion Criteria:
- Males or females age 17 years or older
- Have sickle cell disease, defined as those individuals with HbSS, HbSC, HbSβ0Thal, HbSβ+Thal genotypes
- Receive care at a participating pediatric sickle cell disease center.
- Appropriate for transfer to an adult hematologist within 12 months
Exclusion Criteria:
- Individuals with an intellectual disability that is severe enough that the individual would not have the capacity to interact with a mobile or web-based program even with assistance or have a conversation with a community health worker (i.e. non-verbal).
Sites / Locations
- Connecticut Children's Medical Center
- Cohen's Children's Medical Center
- Cincinnati Children's Hospital Medical Center
- Children's Hospital of Philadelphia
- St. Christophers Hospital for Children
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Enhanced Usual Care
Peer Community Health Worker
Mobile Health
Enhanced usual care will be standardized across sites with transition/transfer of care checklists that will be used at all sites. Enhanced usual care will minimally include (1) patient seen by the pediatric provider with the parent outside the examination room, (2) a social work consult to screen and address sociodemographic risk factors, (3) information on health insurance adequacy provided to patient, (4) adult hematologist identified, (5) adult primary care provider identified, (6) medical release signed, and (7) medical record viewable or sent to adult provider.
The CHW program will primarily be modeled after the highly successful IMPaCT Program developed by the Penn Center for Community Health Workers and CHOP's Youth CHW Program for Pediatric to Adult Transitions developed by our research team, which were both developed with high levels of patient input. SCD specific content and expertise from the CHW Program through the Sickle Cell Disease Association of American Philadelphia Delaware Valley Chapter and other published models will be included. Components will include: 1) development of patient-centered goals and individualized action plan around self-care, symptom tracking, and transition to adult care; 2) provision of information, skills, and tips; and 3) tailored peer support using telephone calls and/or visits
All participants enrolled in the mHealth arm will download an enhanced version of iManage, which was developed by Co-Investigator Lori Crosby at and adolescents and young adult patients with SCD. Components include: 1) development of patient-centered goals around self-care, symptom tracking, and transition to adult care; 2) provision of information, skills, and tips; 3) virtual peer support where users can encourage others to complete goals, forms teams, and interact with other youth with SCD; and 4) daily symptom tracking and visual tracking of goal completion. Investigators will add with daily tailored texting.